Dataset Information


Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo.

ABSTRACT: Sickle red cell (SS RBC) adhesion is believed to contribute to the process of vaso-occlusion in sickle cell disease (SCD). We previously found that the LW RBC adhesion receptor can be activated by epinephrine to mediate SS RBC adhesion to endothelial alphavbeta3 integrin. To determine the contribution of LW activation to vaso-occlusive events in vivo, we investigated whether in vitro treatment of SS RBCs by epinephrine resulted in vaso-occlusion in intact microvasculature after RBC infusion into nude mice. Epinephrine enhanced human SS but not normal RBC adhesion to murine endothelial cells in vitro and to endothelium in vivo, promoting vaso-occlusion and RBC organ sequestration. Murine sickle RBCs also responded to epinephrine with increased adhesion to postcapillary endothelium in nude mice. Epinephrine-induced SS RBC adhesion, vaso-occlusion, and RBC organ trapping could be prevented by the beta-adrenergic receptor (beta-AR) antagonist, propranolol. Infusion of soluble recombinant LW also significantly reduced adhesion and vaso-occlusion. In addition, epinephrine-treated SS RBCs induced activation of murine leukocyte adhesion to endothelium as well. We conclude that LW activation by epinephrine via beta-AR stimulation can promote both SS RBC and leukocyte adhesion as well as vaso-occlusion, suggesting that both epinephrine and LW play potentially pathophysiological roles in SCD.


PROVIDER: S-EPMC1988948 | BioStudies | 2007-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6737414 | BioStudies
1000-01-01 | S-EPMC5232864 | BioStudies
2012-01-01 | S-EPMC3277354 | BioStudies
2016-01-01 | S-EPMC4947547 | BioStudies
2014-01-01 | S-EPMC4435611 | BioStudies
2018-01-01 | S-EPMC6421573 | BioStudies
2016-01-01 | S-EPMC4959913 | BioStudies
1000-01-01 | S-EPMC3984978 | BioStudies
1000-01-01 | S-EPMC3710812 | BioStudies
2019-01-01 | S-EPMC6986874 | BioStudies